22:57:00 EST Fri 06 Feb 2026
Enter Symbol
or Name
USA
CA



NexgenRx Inc
Symbol NXG
Shares Issued 71,117,132
Close 2025-08-11 C$ 0.37
Market Cap C$ 26,313,339
Recent Sedar+ Documents

NexgenRx's Q2 2025 revenue at $4.34-million

2025-08-12 23:30 ET - News Release

Mr. Ronald Loucks reports

NEXGENRX ANNOUNCES SECOND QUARTER RESULTS WITH SIGNIFICANT REVENUE GROWTH AND POSITIVE EBITDA

NexgenRx Inc. has released its financial results for the second quarter ended June 30, 2025, with quarterly revenue growth of $349,043 to $4,346,416 ($8,897,146 year to date) and quarterly EBITDA (earnings before interest, taxes, depreciation and amortization) of $627,631.

The company achieved significant growth in revenue of $349,043, or 8.73 per cent, over the prior-year comparable period, with a positive EBITDA of $627,631. The increased revenue is mainly attributed to organic growth of existing clients as the company expands its reach and services. The company's net income and EBITDA increased by $321,597 and $251,131, respectively, compared with the same period in 2024. The company's cash position remained strong at $2,134,132. The company is well positioned to continue to generate free cash flow, supported by its strong recurring revenues and sales pipelines.

In April, the company secured a new major client from its sales pipeline, a milestone that marks not just a win for the company, but a testament to the trust that the company has built in the marketplace. Since then, the company's IT (information technology) and implementation teams have been hard at work, both on site and through remote technology, in order to plan the implementation and ensure seamless onboarding experience. The dedication of the company's implementation team has not only demonstrated its deep commitment to service but also reinforced the company's core promise: to exceed customers' expectations by understanding their needs with precision and care.

Ron Loucks, president and chief executive officer, stated: "Each success we share is the result of many hands, one mission, and a shared belief that innovation, teamwork and integrity fuel sustainable growth. Because of our strong recurring revenues, robust sales pipelines and exceptional team, we are well positioned to continue building value for our clients, our people and our shareholders."

About NexgenRx Inc.

NexgenRx is Canada's only independent full-service third party administrator and technology solutions provider, offering proprietary full front-end, eligibility, enrolment, hour bank and mobile access capabilities, together with state-of-the-art claims adjudication and full provider network coverage. These combined capabilities allow NexgenRx to provide plan sponsors, sophisticated administration and health benefit technology applications in a cost-effective SaaS (software-as-a-service) model.

NexgenRx is committed to building partnerships with organizations looking to exceed the expectations of their clients and plan members and deliver superior administration and claims processing solutions at a competitive cost.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.